Curated News
By: NewsRamp Editorial Staff
November 04, 2024
PathAI Launches PathExplore™ Fibrosis, an AI-Powered Pathology Breakthrough
TLDR
- Gain an edge in cancer research with PathExplore™ Fibrosis, offering scalable analysis of fibrosis and collagen for new insights.
- PathExplore™ Fibrosis uses AI to quantify fibrosis and collagen directly from whole-slide images, providing new insights into tumor biology.
- PathExplore™ Fibrosis democratizes access to key insights into tumor biology, driving the development of new fibrosis-related therapies for cancer patients.
- Discover how PathExplore™ Fibrosis revolutionizes cancer research by providing new insights into tumor biology and therapeutic response directly from routine pathology images.
Impact - Why it Matters
This news matters as it introduces a transformative AI tool for cancer researchers to explore previously inaccessible aspects of tumor morphology, providing new insights into tumor biology, drug efficacy, and the development of new therapies. Fibrosis and collagen fibers are crucial biomarkers and drug targets, making the introduction of PathExplore™ Fibrosis a significant development in oncology translational research.
Summary
PathAI, a leader in AI-powered pathology solutions, introduces PathExplore™ Fibrosis on their AISight® Translational Research platform. The AI tool is designed to revolutionize fibrosis, collagen, and fiber quantification directly from whole-slide images of hematoxylin and eosin-stained tissue. PathExplore™ Fibrosis offers unprecedented ability to analyze morphology and spatial organization of fibrosis in the tumor microenvironment, providing new insights into tumor biology and therapeutic response. The solution will be presented at the upcoming Society of Immunotherapy of Cancer conference in 2024.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, PathAI Launches PathExplore™ Fibrosis, an AI-Powered Pathology Breakthrough